NCT02265965View on ClinicalTrials.gov

Trial of IV NTG for CD After Second Stage Arrest for the Prevention of Uterine Extension

PHASE4CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

July 1, 2018

Study Completion Date

July 1, 2018

Conditions
Prolonged Second Stage of Labor
Interventions
DRUG

intravenous nitroglycerin

Infusion at started at time of hysterotomy and stopped at neonate delivery

Trial Locations (1)

94143

University California San Francisco-Labor and Delivery, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT02265965 - Trial of IV NTG for CD After Second Stage Arrest for the Prevention of Uterine Extension | Biotech Hunter | Biotech Hunter